Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE: Rituximab in Rheumatoid Arthritis
NCT00147966Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by University of California, San Diego. Primary endpoint: American College of Rheumatology 20% Improvement at 12 weeks. Started Jun 2008; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00147966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147966.